[儿童牛皮的治疗:现在和未来]
Francesco Messina1,2, Curdin Conrad1, Marie-Anne Morren3
1Département de dermatologie et vénéréologie, Centre hospitalier universitaire vaudois, Université de Lausanne, 1011 Lausanne.
Revue medicale suisse
|April 2, 2024
概括
儿童牛皮,影响皮肤,指甲和关节,显著影响生活质量. 本概述详细介绍了儿科牛皮的治疗方法,包括新兴的生物疗法.
科学领域:
- 儿科皮肤病学 儿科皮肤病学
- 类风湿病学 类风湿病学
- 免疫皮肤学 免疫皮肤学
背景情况:
- 儿童的牛皮可以表现为各种皮肤,指甲和头皮病变.
- 儿科牛皮经常涉及关节并发症,导致显著的生活质量受损.
- 早期诊断和管理对于减轻长期影响至关重要.
研究的目的:
- 为儿科患者提供当前和新兴的牛皮治疗方法的全面概述.
- 根据受影响的皮肤区域和病变严重程度对治疗选择进行分类.
- 突出生物治疗在儿童牛皮的作用和潜力.
主要方法:
- 小儿牛皮治疗指南和临床试验的文献综述.
- 对各种治疗类的治疗疗效和安全数据的分析.
- 专注于全身疗法,包括常规和生物药物.
主要成果:
- 治疗选择以病变的位置,程度和严重程度为指导.
- 局部治疗是局部疾病的第一线治疗方法,而全身治疗只适用于中度至严重的病例.
- 生物药物在儿科牛皮症中显示出显著的疗效和改善的安全性.
结论:
- 为了有效地管理儿科牛皮,多模式方法至关重要.
- 生物疗法代表了治疗严重儿童牛皮的有希望的进展.
- 对儿童生物治疗的长期结果进行进一步研究是有必要的.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
116
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
116
Skin Cancer
4.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
162
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
162
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
Drugs for Treatment of Ulcerative Colitis in IBD
138
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
138


